封面
市場調查報告書
商品編碼
2032472

靜脈輸液(IV)治療和靜脈通路市場:按類型、應用、最終用戶和地區分類(2026-2034 年)

Intravenous Therapy and Vein Access Market by Type, Application, End User, and Region 2026-2034

出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2025年,全球靜脈輸液和靜脈通路市場規模達274億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到403億美元,2026年至2034年的複合年成長率為4.23%。慢性病盛行率上升、交通事故發生率增加以及消費者對靜脈輸液益處的認知不斷提高是推動市場成長的主要因素。

靜脈輸液療法是一種醫療程序,透過靜脈將體液、藥物和營養素直接注射到血液中。這種方法常用於醫院、診所和其他醫療機構,用於治療各種症狀和疾病。靜脈通路是指將針頭插入靜脈進行靜脈輸液的過程。通常,醫護人員會用針頭刺穿皮膚進入靜脈,但由於靜脈狹窄或受損、脫水或肥胖等因素,這對某些患者來說可能比較困難。靜脈輸液療法有多種類型,包括用於治療脫水的生理食鹽水、用於治療感染疾病的抗生素以及用於癌症治療的化療。除了治療疾病外,靜脈輸液療法也用於預防,例如接種疫苗和補充維生素。

靜脈輸液治療與靜脈通路市場的發展趨勢:

癌症、糖尿病和自體免疫疾病等需要長期用藥和監測的慢性病和文明病的日益普遍,是推動全球靜脈輸液和靜脈通路市場成長的主要因素。此外,交通事故率的上升和創傷病例的激增也促進了市場成長。消費者對靜脈輸液和靜脈通路益處的認知不斷提高,以及重症監護的普及,為市場創造了盈利的成長機會。同時,微創手術的普及也是推動市場成長的關鍵因素。此外,醫療產業眾多旨在減少所需時間和精力、降低感染風險和提高手術精準度的技術偏好,也為市場帶來了良好的前景。同時,對新治療方法、藥品和醫療設備創新研發活動的大規模投資,也推動了市場擴張。最後,醫療保健支出的成長、醫院數量的增加、居家醫療的普及以及老年人口的成長,都進一步增強了市場成長的動力。

本報告解答的主要問題

  • 全球靜脈輸液(IV)治療和靜脈通路市場迄今的發展軌跡如何?預計未來幾年將如何發展?
  • 全球靜脈輸液(IV)治療和靜脈通路市場的促進因素、阻礙因素和機會是什麼?
  • 各種促進因素​​、阻礙因素和機會如何影響全球靜脈輸液(IV)治療和靜脈通路市場?
  • 主要區域市場有哪些?
  • 哪些國家構成了最具吸引力的靜脈輸液(IV)治療和靜脈通路市場?
  • 按類型分類的市場組成是什麼?
  • 在靜脈輸液(IV)治療和靜脈通路市場中,哪種類型最具吸引力?
  • 按應用領域分類的市場區隔如何?
  • 靜脈輸液和靜脈通路市場中最具吸引力的應用有哪些?
  • 依最終用戶分類的市場區隔如何?
  • 在靜脈輸液(IV)治療和靜脈通路市場中,哪些終端使用者最具吸引力?
  • 全球靜脈輸液和靜脈通路市場的競爭格局如何?
  • 全球靜脈輸液(IV)治療和靜脈通路市場的主要參與者/公司有哪些?

目錄

第1章:序言

第2章:調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章:引言

第5章:全球靜脈輸液(IV)治療與靜脈通路市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔:依類型

  • 嵌入式連接埠
  • 靜脈導管
  • 皮下注射針
  • 點滴幫浦
  • 其他

第7章 市場區隔:依應用領域分類

  • 營養補充品和緩衝劑
  • 容積擴張器
  • 藥物管理
  • 血液製品

第8章 市場區隔:依最終用戶分類

  • 醫院
  • 門診手術中心
  • 診所

第9章 市場區隔:依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章:促進、抑制與機遇

第11章:價值鏈分析

第12章:波特五力分析

第13章:價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • AngioDynamics Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Cardinal Health Inc.
    • Fresenius SE & Co. KGaA
    • ICU Medical Inc.
    • Medtronic plc
    • Tekni-Plex Inc.
    • Teleflex Incorporated
    • Terumo Corporation
    • Vygon SAS
Product Code: SR112026A7524

The global intravenous (IV) therapy and vein access market size reached USD 27.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 40.3 Billion by 2034, exhibiting a growth rate (CAGR) of 4.23% during 2026-2034. The growing prevalence of chronic diseases, the increasing incidences of road accidents, and the rising consumer awareness about the benefits of IV therapy represent some of the key factors driving the market.

Intravenous (IV) therapy is a medical procedure that involves administering fluids, medications, and nutrition directly into the bloodstream through a vein. This technique is commonly used in hospitals, clinics, and other healthcare facilities to treat various conditions and illnesses. Vein access is the process of entering a vein in order to administer IV therapy. A healthcare professional typically uses a needle to puncture the skin and access a vein, which can be challenging in some patients due to factors such as small or damaged veins, dehydration, and obesity. There are several types of IV therapy, including saline solutions for dehydration, antibiotics for infections, and chemotherapy for cancer treatment. In addition to treating medical conditions, IV therapy can also be used for preventative measures, such as receiving vaccinations and vitamins.

INTRAVENOUS (IV) THERAPY AND VEIN ACCESS MARKET TRENDS:

The increasing prevalence of chronic and lifestyle diseases, such as cancer, diabetes, and autoimmune diseases that require long-term medication and monitoring, is primarily driving the global intravenous (IV) therapy and vein access market growth. Besides this, the rising incidences of road accidents and the surging number of trauma cases are contributing to the market growth. Moreover, the escalating consumer awareness about the benefits of IV therapy and vein access and the rise in critical care therapies are presenting remunerative growth opportunities for the market. In line with this, the shifting preference for minimally invasive procedures is acting as another significant growth-inducing factor. In addition to this, numerous technological advancements in the healthcare industry to reduce the needed time and effort, lower the risk of infection, and improve the accuracy of the procedure are creating a positive outlook for the market. Concurrent with this, extensive investments in research and development (R&D) activities for innovating new therapies, drugs, and devices are aiding in market expansion. Furthermore, the increasing healthcare expenditure, rise in the number of hospitals, the widespread adoption of home healthcare, and the expanding geriatric population are strengthening the market growth.

KEY MARKET SEGMENTATION:

Type Insights:

  • Implantable Ports
  • Intravenous Catheters
  • Hypodermic Needles
  • Infusion Pumps
  • Others

Application Insights:

  • Nutrition and Buffer Solution
  • Volume Expander
  • Medication Administration
  • Blood Based Products

End User Insights:

  • Hospitals
  • Ambulatory Surgical Center
  • Clinics

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intravenous (IV) therapy and vein access. Some of the factors driving the North America intravenous (IV) therapy and vein access market included the growing prevalence of chronic diseases, the increasing number of road accidents, and the expanding geriatric population.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global intravenous (IV) therapy and vein access market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AngioDynamics Inc., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Fresenius SE & Co. KGaA, ICU Medical Inc., Medtronic plc, Tekni-Plex Inc., Teleflex Incorporated, Terumo Corporation, Vygon SAS, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global intravenous (IV) therapy and vein access market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global intravenous (IV) therapy and vein access market?
  • What is the impact of each driver, restraint, and opportunity on the global intravenous (IV) therapy and vein access market?
  • What are the key regional markets?
  • Which countries represent the most attractive intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the intravenous (IV) therapy and vein access market?
  • What is the competitive structure of the global intravenous (IV) therapy and vein access market?
  • Who are the key players/companies in the global intravenous (IV) therapy and vein access market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous (IV) Therapy and Vein Access Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Implantable Ports
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intravenous Catheters
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hypodermic Needles
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Infusion Pumps
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Nutrition and Buffer Solution
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Volume Expander
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Medication Administration
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Blood Based Products
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Center
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AngioDynamics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cardinal Health Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Fresenius SE & Co. KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 ICU Medical Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Tekni-Plex Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Teleflex Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Terumo Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Vygon SAS
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Intravenous Therapy and Vein Access Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Therapy and Vein Access Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Intravenous Therapy and Vein Access Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Intravenous Therapy and Vein Access Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Intravenous Therapy and Vein Access Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Intravenous Therapy and Vein Access Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Intravenous Therapy and Vein Access (Implantable Ports) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Intravenous Therapy and Vein Access (Implantable Ports) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Intravenous Therapy and Vein Access (Intravenous Catheters) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Intravenous Therapy and Vein Access (Intravenous Catheters) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Intravenous Therapy and Vein Access (Hypodermic Needles) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Intravenous Therapy and Vein Access (Hypodermic Needles) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Intravenous Therapy and Vein Access (Infusion Pumps) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Intravenous Therapy and Vein Access (Infusion Pumps) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Intravenous Therapy and Vein Access (Other Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Intravenous Therapy and Vein Access (Other Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Intravenous Therapy and Vein Access (Nutrition and Buffer Solution) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Intravenous Therapy and Vein Access (Nutrition and Buffer Solution) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Intravenous Therapy and Vein Access (Volume Expander) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Intravenous Therapy and Vein Access (Volume Expander) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Intravenous Therapy and Vein Access (Medication Administration) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Intravenous Therapy and Vein Access (Medication Administration) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Intravenous Therapy and Vein Access (Blood Based Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Intravenous Therapy and Vein Access (Blood Based Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Intravenous Therapy and Vein Access (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Intravenous Therapy and Vein Access (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Intravenous Therapy and Vein Access (Ambulatory Surgical Center) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Intravenous Therapy and Vein Access (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Intravenous Therapy and Vein Access (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Intravenous Therapy and Vein Access (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: North America: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: North America: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: United States: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: United States: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Canada: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Canada: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Asia-Pacific: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Asia-Pacific: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: China: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: China: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Japan: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Japan: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: India: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: India: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: South Korea: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: South Korea: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Australia: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Australia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Indonesia: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Indonesia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Europe: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Europe: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Germany: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Germany: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: France: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: France: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: United Kingdom: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: United Kingdom: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Italy: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Italy: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Spain: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Spain: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Russia: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Russia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Latin America: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Latin America: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Brazil: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Brazil: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Mexico: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Mexico: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Middle East and Africa: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Middle East and Africa: Intravenous Therapy and Vein Access Market: Breakup by Country (in %), 2025
  • Figure 80: Middle East and Africa: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Global: Intravenous Therapy and Vein Access Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Intravenous Therapy and Vein Access Industry: Value Chain Analysis
  • Figure 83: Global: Intravenous Therapy and Vein Access Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intravenous Therapy and Vein Access Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Intravenous Therapy and Vein Access Market: Competitive Structure
  • Table 7: Global: Intravenous Therapy and Vein Access Market: Key Players